{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:56:21Z","timestamp":1648738581382},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.ccl.2007.08.007","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T11:57:32Z","timestamp":1196942252000},"page":"539-551","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacologic Therapy for Acute Heart Failure"],"prefix":"10.1016","volume":"25","author":[{"given":"W. H. Wilson","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 7","key":"10.1016\/j.ccl.2007.08.007_bib1","first-page":"S21","article-title":"The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure","volume":"4","author":"Fonarow","year":"2003","journal-title":"Rev Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.ccl.2007.08.007_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ahj.2004.05.051","article-title":"B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure","volume":"149","author":"O'Neill","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2007.08.007_bib3","doi-asserted-by":"crossref","first-page":"984.e1","DOI":"10.1016\/j.ahj.2005.07.031","article-title":"Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study","volume":"150","author":"James","year":"2005","journal-title":"Am Heart J"},{"issue":"16","key":"10.1016\/j.ccl.2007.08.007_bib4","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2006.10.081","article-title":"Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study","volume":"49","author":"Jourdain","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.ccl.2007.08.007_bib5","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1161\/CIRCULATIONAHA.106.666255","article-title":"N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study","volume":"115","author":"Moe","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2007.08.007_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ccl.2007.08.007_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2796.1994.tb01082.x","article-title":"Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance","volume":"235","author":"van Meyel","year":"1994","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.ccl.2007.08.007_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","article-title":"Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion","volume":"28","author":"Dormans","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2007.08.007_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003178.pub3","article-title":"Continuous infusion versus bolus injection of loop diuretics in congestive heart failure","author":"Salvador","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ccl.2007.08.007_bib10","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.cardfail.2005.11.017","article-title":"Evaluation and management of patients with acute decompensated heart failure","volume":"12","author":"Heart Failure Society of America","year":"2006","journal-title":"J Card Fail"},{"issue":"2","key":"10.1016\/j.ccl.2007.08.007_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0009-9236(97)90067-9","article-title":"Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure","volume":"62","author":"Cotter","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ccl.2007.08.007_bib12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00003495-199855020-00001","article-title":"Combination diuretic therapy in severe congestive heart failure","volume":"55","author":"Dormans","year":"1998","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ccl.2007.08.007_bib13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis","volume":"293","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ccl.2007.08.007_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1054\/jcaf.2002.125289","article-title":"The prognostic importance of different definitions of worsening renal function in congestive heart failure","volume":"8","author":"Gottlieb","year":"2002","journal-title":"J Card Fail"},{"issue":"12","key":"10.1016\/j.ccl.2007.08.007_bib15","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2005.01.059","article-title":"Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study","volume":"45","author":"Paterna","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.ccl.2007.08.007_bib16","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.ccl.2007.08.007_bib17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2005.11.071","article-title":"Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients","volume":"47","author":"Abraham","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ccl.2007.08.007_bib18","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.jacc.2007.01.091","article-title":"Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction","volume":"49","author":"Udelson","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ccl.2007.08.007_bib19","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","article-title":"Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials","volume":"297","author":"Gheorghiade","year":"2007","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ccl.2007.08.007_bib20","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccl.2007.08.007_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.ccl.2007.08.007_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/eurheartj\/ehi044","article-title":"Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology","volume":"26","author":"Nieminen","year":"2005","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.ccl.2007.08.007_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJM197409192911201","article-title":"Treatment of refractory heart failure with infusion of nitroprusside","volume":"291","author":"Guiha","year":"1974","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ccl.2007.08.007_bib24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0735-1097(02)01814-4","article-title":"Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure","volume":"39","author":"Johnson","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2007.08.007_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.RES.39.1.127","article-title":"Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure: differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation","volume":"39","author":"Miller","year":"1976","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.ccl.2007.08.007_bib26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0002-8703(97)70030-9","article-title":"Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function","volume":"134","author":"Capomolla","year":"1997","journal-title":"Am Heart J"},{"issue":"19","key":"10.1016\/j.ccl.2007.08.007_bib27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJM198205133061902","article-title":"Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study","volume":"306","author":"Cohn","year":"1982","journal-title":"N Engl J Med"},{"issue":"9100","key":"10.1016\/j.ccl.2007.08.007_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ccl.2007.08.007_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/107424840400900403","article-title":"Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations","volume":"9","author":"Elkayam","year":"2004","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ccl.2007.08.007_bib30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM200007273430403","article-title":"Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group","volume":"343","author":"Colucci","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ccl.2007.08.007_bib31","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/01.CIR.0000141829.04031.25","article-title":"Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine","volume":"110","author":"Wang","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccl.2007.08.007_bib32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0735-1097(99)00184-9","article-title":"Sustained hemodynamic effects of an infusion of nesiritide (human B-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group","volume":"34","author":"Mills","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2007.08.007_bib33","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.287.12.1531","article-title":"Publication Committee for the VMAC (Vasodilation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","volume":"287","year":"2002","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ccl.2007.08.007_bib34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.0000159340.93220.E4","article-title":"Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure","volume":"111","author":"Sackner-Bernstein","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2007.08.007_bib35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ahj.2007.02.004","article-title":"The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design","volume":"153","author":"Yancy","year":"2007","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.ccl.2007.08.007_bib36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacc.2006.10.048","article-title":"Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA trial","volume":"49","author":"Mentzer","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.ccl.2007.08.007_bib37","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1001\/jama.293.15.1900","article-title":"Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials","volume":"293","author":"Sackner-Bernstein","year":"2005","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ccl.2007.08.007_bib38","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ahj.2006.07.002","article-title":"Short and long-term mortality with nesiritide","volume":"152","author":"Arora","year":"2006","journal-title":"Am Heart J"},{"issue":"15","key":"10.1016\/j.ccl.2007.08.007_bib39","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1001\/jama.296.15.1877","article-title":"Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure","volume":"296","author":"Hauptman","year":"2006","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.ccl.2007.08.007_bib40","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/eurheartj\/ehl337","article-title":"Haemodynamic and clinical effects of ularitide in decompensated heart failure","volume":"27","author":"Mitrovic","year":"2006","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ccl.2007.08.007_bib41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJM199209033271002","article-title":"Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)","volume":"327","author":"Swedberg","year":"1992","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ccl.2007.08.007_bib42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ejheart.2004.05.004","article-title":"The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A\/B receptor antagonist) in patients with acute heart failure","volume":"6","author":"Cotter","year":"2004","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.ccl.2007.08.007_bib43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0735-1097(03)00556-4","article-title":"Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure","volume":"42","author":"Torre-Amione","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2007.08.007_bib44","article-title":"A double-blind, parallel-group, multi-center, placebo-controlled study to investigate the efficacy and safety of tezosentan in reducing symptoms in patients with acute decompensated heart failure","volume":"104","author":"Teerlink","year":"2001","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ccl.2007.08.007_bib45","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","article-title":"Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure: The VERITAS Randomized Controlled Trials","volume":"298","author":"McMurray","year":"2007","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ccl.2007.08.007_bib46","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0002-9149(91)90507-H","article-title":"Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure","volume":"68","author":"Binkley","year":"1991","journal-title":"Am J Cardiol"},{"issue":"6A","key":"10.1016\/j.ccl.2007.08.007_bib47","doi-asserted-by":"crossref","first-page":"47G","DOI":"10.1016\/j.amjcard.2005.07.021","article-title":"Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes","volume":"96","author":"Bayram","year":"2005","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2007.08.007_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2007.08.007_bib49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ahj.2006.09.005","article-title":"Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure","volume":"153","author":"Elkayam","year":"2007","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2007.08.007_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.69.1.113","article-title":"Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine","volume":"69","author":"Liang","year":"1984","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ccl.2007.08.007_bib51","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1067\/mhj.2002.125620","article-title":"Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study","volume":"144","author":"Burger","year":"2002","journal-title":"Am Heart J"},{"issue":"1 Pt 1","key":"10.1016\/j.ccl.2007.08.007_bib52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-8703(99)70250-4","article-title":"Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)","volume":"138","author":"O'Connor","year":"1999","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.ccl.2007.08.007_bib53","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1067\/mhj.2001.119610","article-title":"Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: hemodynamic efficacy, clinical outcome, and economic impact","volume":"142","author":"Yamani","year":"2001","journal-title":"Am Heart J"},{"issue":"12","key":"10.1016\/j.ccl.2007.08.007_bib54","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ccl.2007.08.007_bib55","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study","volume":"41","author":"Felker","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"9328","key":"10.1016\/j.ccl.2007.08.007_bib56","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ccl.2007.08.007_bib57","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double-blind study (RUSSLAN)","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ccl.2007.08.007_bib58","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejheart.2004.04.014","article-title":"Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure","volume":"6","author":"Cleland","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ccl.2007.08.007_bib59","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/S1071-9164(03)00532-3","article-title":"Development of a comprehensive new endpoint for the evaluation of new treatments of acute decompensated heart failure: results with levosimendan in the REVIVE-1 study","volume":"9","author":"Packer","year":"2003","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.ccl.2007.08.007_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejheart.2005.12.003","article-title":"Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE","volume":"8","author":"Cleland","year":"2006","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"10.1016\/j.ccl.2007.08.007_bib61","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865107000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865107000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T02:27:31Z","timestamp":1546396051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865107000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0733865107000793"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2007.08.007","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}